The information can also be accessed by caregivers and physicians through a web-based portal, but patients have to grant access.
What is the pill approved to treat?
Abilify MyCite is approved for the treatment of schizophrenia, acute treatment of manic and mixed episodes associated with bipolar I disorder. The pill can also be administered as an add-on treatment for depression in adults, according to the FDA press release.
But “being able to track ingestion of medications prescribed for mental illness may be useful for some patients,” Mitchell Mathis, director of the division of psychiatry products in the FDA’s Center for Drug Evaluation and Research, said.
Who created the pill?
According to the news release, the FDA granted the approval of Abilify MyCite to Otsuka Pharmaceutical Co., Ltd. The technology in the sensors and the patch were developed by Proteus Digital Health.